Gilead re­news IT con­tract with Cog­nizant in bid to more quick­ly bring drugs to mar­ket 

Gilead is ex­pand­ing and re­new­ing an IT con­tract with Cog­nizant that is now worth up to $800 mil­lion over five years.

Cog­nizant

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA